I AM BIO

I AM BIO

By Biotechnology Innovation OrganizationNewsScienceMedicineHealth & FitnessPoliticsLife Sciences
Download on the App Store

I AM BIO episodes

  • Green Fuels Have Taken Off (Redux)

    Last December, a United Airlines’ flight from Chicago to Washington DC was the first ever passenger flight powered with 100% sustainable aviation fuel. The achievement demonstrated the potential for the aviation sector to reduce its carbon footprint. Our guests in this episode each played a key role in in helping the airline reach this exciting milestone.

    20 min
  • Antimicrobial Resistance: The Silent Pandemic (Redux)

    We are on the precipice of a looming crisis. Antimicrobial resistance (AMR) is the evolution of deadly pathogens like bacteria and fungi to resist all current antimicrobial medicines. In this episode, we talk about how the dwindling supply of new antibiotics is fueling this silent pandemic, and why we need a continued pipeline of new antibiotics to avoid this crisis.

    Guests:

    Ankit Mahadevia, Spero Therapeutics

    Henry  Skinner, AMR Action Fund

    Mary Dwight, Cystic Fibrosis Foundation 

    27 min
  • New Season of I am BIO; plus Hope for Alzheimer's (Redux)

    I am BIO will begin a new season of exciting topics on Feb 28. During our hiatus, we are bringing back some of our most popular episodes beginning with “Hope for Alzheimer's.”

    Alzheimer’s disease is a heartbreaking diagnosis and tragically there is no cure. But every day, researchers, scientists and the medical community are working to change that. In this episode, we speak with three guests who are fighting to bend the trajectory of Alzheimer’s disease and, in doing so, offering hope for the millions suffering from this devastating illness.

    23 min
  • Let’s Get Uncomfortable: Talking About Women’s Health

    Talking about women’s health has been a taboo subject for some time, contributing to a lack of innovation in the sector. Still today, many are uncomfortable discussing the topic. Consequently, only 2% of medical products in the pipeline are for women’s health and only 2% of all venture capital dollars go into developing these products. In this episode, we talk with two women in biotech who are trying to change that narrative and infuse more investment in innovations that meet the needs of half the population.

    Sabrina Martucci Johnson, CEO
    Daré Bioscience

    Elizabeth Baily, Managing Director
    RH Capital

     

    25 min
  • Microbes, Bioplastics … and Art: Solutions to Plastic Pollution

    Plastic is polluting our waterways and oceans, but biotechnology may deliver solutions. Plant-based bioplastics that can break down in months are one solution. Another is mighty microbes bioengineered to speed up consumption of plastic. This episode spotlights scientists, companies and even a filmmaker and artist who are working in different ways to tackle the growing problem of plastic waste. 

    Guests:

    Scott Tuten, Chief Marketing and Sustainability Officer, Danimer Scientific

    Andrew Held, Vice President of Engineering & Business, Virent

    Dr. Tae Seok Moon, Associate Professor of Energy, Environmental & Chemical Engineering, Washington University in St. Louis, Founder and head of the Scientific Advisory Board, Moonshot Bio

    Ben Lear, Independent Film Producer/Director

    25 min
  • Psychedelics – Not Just For Hippies Anymore

    Not that long ago psychedelics were considered dangerous, and only enjoyed recreationally by a fringe element of society. Today, researchers are looking at drugs like psilocybin to develop treatments for depression, PTSD, addiction, and anxiety. This episode features guests steeped in the world of psychedelics who are finding new ways to treat mental health. 

    Guests:

    Dr. Frank Wiegand, Chief Medical Officer, Beckley Psytech

    Kurt Rasmussen, Ph.D., Chief Scientific Officer, Delix Therapeutics

    Clara Burtenshaw, Co-founder and Partner, Neo Kuma Ventures

    21 min
  • The Surprising Role of Patient Advocates in Drug Development

    Patient Advocates do more than raise money—they are active participants in the drug development process. While the ALS Ice Bucket Challenge garnered global attention, lesser-known patient advocates also flex their expertise to drive new treatments and cures.  In this episode, we talk with two moms, one who is a patient herself, about their work as partners in research and development, helping bring treatments for two rare diseases to the market. 

    Susan Ruediger, Founder and Chief Mission Officer, CMT Research Foundation  

    Nasha Fitter, CEO, FOXG1 Research Foundation  
     

    21 min
  • Lessons from Monkeypox: Are We Prepared for the Next Pandemic?

    Monkeypox hit our shores in May of this year. How did our public health agencies and infrastructure perform? What went right, what went wrong, and what needs to improve? We talked with three experts in public health and biodefense about the threats on their radar screens and how the U.S. can better prepare for the next inevitable outbreak or pandemic.

    Guests:

    Dr. Asha George, Bipartisan Commission on Biodefense

    Dr. Lynn Goldman, Milken Institute School of Public Health at the George Washington University

    Dr. John Redd, Medical Countermeasures Coalition 

    18 min
  • Data Storage Crisis: DNA to the Rescue

    You might be surprised to learn that data storage currently requires huge amounts of land and energy, and we're running out of both. In this episode, we speak with a small group of researchers who are working to revolutionize the way we store the massive amounts of data we produce every day. Their solution: use DNA.

    Speakers:

    • Emily Leproust, Twist Bioscience
    • Jeff Nivala, University of Washington
    • Kyle Tomek, DNAli Technologies
    26 min
  • Investors Become Goldilocks in a Bear Market

    Current market trends have put investors in a “flight-to-safety” mentality, especially when it comes to biotech companies. What does this mean for getting biotech innovations to the marketplace? This episode explores the daunting challenge of raising capital in a bear market.

    Speakers:

    • Bill Newell, Sutro Biopharma
    • Dr. Lisa Drakeman, Biotech Entrepreneur
    • Sougato Das, PRISM.science

     

    26 min

About I AM BIO

From the publisher's feed

Powerful stories of biotechnology breakthroughs, the people they help, and the global problems they solve.

More shows like I AM BIO

This Week in Virology by Vincent Racaniello

This Week in Virology

2,053 Listeners

Nature Podcast by Springer Nature Limited

Nature Podcast

769 Listeners

TED Talks Science and Medicine by TED

TED Talks Science and Medicine

756 Listeners

Science Talk by Scientific American

Science Talk

600 Listeners

Science Magazine Podcast by Science Magazine

Science Magazine Podcast

817 Listeners

Two Scientists Walk Into a Bar by Genentech

Two Scientists Walk Into a Bar

310 Listeners

The Daily by The New York Times

The Daily

112,266 Listeners

Interchange Recharged by Wood Mackenzie

Interchange Recharged

505 Listeners

FYI - For Your Innovation by ARK Invest

FYI - For Your Innovation

394 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

124 Listeners

The Readout Loud by STAT

The Readout Loud

348 Listeners

The World, the Universe and Us by New Scientist

The World, the Universe and Us

119 Listeners

Raising Health by Andreessen Horowitz, a16z Bio + Health

Raising Health

149 Listeners

Catalyst with Shayle Kann by Latitude Media

Catalyst with Shayle Kann

280 Listeners

What's Your Problem? by iHeartPodcasts and Pushkin Industries

What's Your Problem?

273 Listeners